The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISAL 2019 | Single cell sequencing of AML: elucidating clonal heterogeneity
Klaus Metzeler, MD, of LMU Hospital Munich, Munich, Germany, discusses his group’s work on the genotyping and single cell RNA sequencing of acute myeloid leukemia (AML) patients with subclonal mutations, with the long-term aim of identifying novel therapeutic targets and better understanding the disease. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
